Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

2.

Development and applications of single-cycle infectious influenza A virus (sciIAV).

Nogales A, Baker SF, Domm W, Martínez-Sobrido L.

Virus Res. 2016 May 2;216:26-40. doi: 10.1016/j.virusres.2015.07.013.

PMID:
26220478
3.

Viral evolution: Influenza evolves - From rhetoric to reality?

Damle SG.

Contemp Clin Dent. 2015 Mar;6(Suppl 1):S3-4. doi: 10.4103/0976-237X.152929. No abstract available.

4.

Amino acid substitutions in hemagglutinin of the 2009 pandemic influenza A(H1N1) viruses that might affect the viral antigenicity.

Kosoltanapiwat N, Boonyuen U, Pooruk P, Iamsirithaworn S, Mungaomklang A, Chokephaibulkit K, Auewarakul P, Puthavathana P.

BMC Res Notes. 2014 Dec 23;7:951. doi: 10.1186/1756-0500-7-951.

5.

Epidemiological aspects of influenza A related to climatic conditions during and after a pandemic period in the city of Salvador, Northeastern Brazil.

Silva Rde C, Siqueira MA, Netto EM, Bastos JS, Nascimento-Carvalho CM, Vilas-Boas AL, Bouzas ML, Motta Fdo C, Brites C.

Mem Inst Oswaldo Cruz. 2014 Apr;109(2):229-35.

6.

Clinical differences between H3N2 and H1N1 influenza 2012 and lower respiratory tract infection found using a statistical classification approach.

Petridis D, Zarogoulidis P, Kallianos A, Kioumis I, Trakada G, Spyratos D, Papaiwannou A, Porpodis K, Huang H, Rapti A, Hohenforst-Schmidt W, Zarogoulidis K.

Ther Clin Risk Manag. 2014 Feb 7;10:77-86. doi: 10.2147/TCRM.S57429.

7.

Effectiveness of neuraminidase inhibitors in preventing hospitalization during the H1N1 influenza pandemic in British Columbia, Canada.

Marra F, Chong M, Henry B, Patrick DM, Kendall P.

J Antimicrob Chemother. 2014 May;69(5):1397-406. doi: 10.1093/jac/dkt496.

8.

Drug susceptibility surveillance of influenza viruses circulating in the United States in 2011-2012: application of the WHO antiviral working group criteria.

Okomo-Adhiambo M, Nguyen HT, Abd Elal A, Sleeman K, Fry AM, Gubareva LV.

Influenza Other Respir Viruses. 2014 Mar;8(2):258-65. doi: 10.1111/irv.12215.

9.

Clinical and radiological characteristics of 2009 H1N1 influenza associated pneumonia in young male adults.

Lee JE, Choe KW, Lee SW.

Yonsei Med J. 2013 Jul;54(4):927-34. doi: 10.3349/ymj.2013.54.4.927.

10.

The Neurological Manifestations of H1N1 Influenza Infection; Diagnostic Challenges and Recommendations.

Asadi-Pooya AA, Yaghoubi E, Nikseresht A, Moghadami M, Honarvar B.

Iran J Med Sci. 2011 Mar;36(1):36-9.

11.

Rise of the microbes.

Mahan MJ, Kubicek-Sutherland JZ, Heithoff DM.

Virulence. 2013 Apr 1;4(3):213-22. doi: 10.4161/viru.23380. Review.

12.

Characteristics and outcome of critically ill patients with 2009 H1N1 influenza infection in Syria.

Alsadat R, Dakak A, Mazlooms M, Ghadhban G, Fattoom S, Betelmal I, Abouchala N, Kherallah M.

Avicenna J Med. 2012 Apr;2(2):34-7. doi: 10.4103/2231-0770.99156.

13.

Pandemic influenza A virus codon usage revisited: biases, adaptation and implications for vaccine strain development.

Goñi N, Iriarte A, Comas V, Soñora M, Moreno P, Moratorio G, Musto H, Cristina J.

Virol J. 2012 Nov 8;9:263. doi: 10.1186/1743-422X-9-263.

14.

Effect of fever on hospital presentation, diagnosis, and treatment in patients with H1N1/09 influenza.

Sopirala MM, Haas DM, Ali NA, Mangino JE, Pan X, Turner AN.

J Hosp Med. 2013 Jan;8(1):20-4. doi: 10.1002/jhm.1981.

15.

Clinical differences between influenza A (H1N1) virus and respiratory infection between the two waves in 2009 and 2010.

Zarogoulidis P, Glaros D, Kioumis I, Terzi E, Porpodis K, Tsiotsios A, Kallianos A, Trakada G, Machairiotis N, Stylianaki A, Sakas A, Rapti A, Courcoutsakis N, Constantinidis TC, Maltezos E, Zarogoulidis K.

Int J Gen Med. 2012;5:675-82. doi: 10.2147/IJGM.S34940.

16.

Clinical Features and Outcome of 65 Laboratory Confirmed Cases of H1N1 in Muscat, Sultanate of Oman.

Pajankar S, Al Qassabi SS, Al Harthi SM.

Oman Med J. 2012 May;27(3):201-6. doi: 10.5001/omj.2012.46.

17.

Oseltamivir resistance in swine influenza: a brief discussion.

Wiwanitkit V.

N Am J Med Sci. 2009 Aug;1(3):96-8.

18.

Factors mediating seasonal and influenza A (H1N1) vaccine acceptance among ethnically diverse populations in the urban south.

Frew PM, Painter JE, Hixson B, Kulb C, Moore K, del Rio C, Esteves-Jaramillo A, Omer SB.

Vaccine. 2012 Jun 13;30(28):4200-8. doi: 10.1016/j.vaccine.2012.04.053.

19.

Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus.

Yang SG, Cao B, Liang LR, Li XL, Xiao YH, Cao ZX, Jia HY, Yu HJ, Xu Z, Gu L, Yang YD, Chen Y, Du WB, Yan XX, Liang ZA, Zhang W, Zhang CL, Chen W, Guo CP, Jiang XL, Yang M, Deng GM, Yu KJ, Hu K, Zou Q, Li LJ, Wang C; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China..

PLoS One. 2012;7(1):e29652. doi: 10.1371/journal.pone.0029652.

20.
Items per page

Supplemental Content

Support Center